We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Benefits of Male Circumcision—Reply

Aaron A. R. Tobian, MD, PhD; Ronald H. Gray, MD, MSc
JAMA. 2012;307(5):455-457. doi:10.1001/jama.2012.63.
Text Size: A A A
Published online


In Reply: We agree with Dr Masem that medical recommendations should be “based on the effective treatment of disease.” It was not possible in a Commentary to review all studies of male circumcision, so we focused on the randomized trials, the criterion standard of evidence-based medicine. All 3 circumcision trials demonstrated remarkable consistency in the efficacy of male circumcision to reduce STIs, similar to that reported in numerous observational studies and meta-analyses.1,2 In addition, the majority of observational studies demonstrate that neonatal male circumcision reduces urinary tract infections and penile inflammatory disorders, such as meatitis, balanitis, and phimosis, as mentioned by Drs Klausner and Morris. One randomized trial demonstrated that male circumcision of HIV-positive men did not have an impact on either HIV or high-risk human papillomavirus transmission to female partners over 2 years.3,4 However, observational studies suggest possible longer-term benefit in women whose partners were circumcised during infancy.5


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




February 1, 2012
Jeffrey D. Klausner, MD, MPH; Brian J. Morris, PhD, DSc
JAMA. 2012;307(5):455-457. doi:10.1001/jama.2012.60.
February 1, 2012
Julie M. Croff, PhD, MPH
JAMA. 2012;307(5):455-457. doi:10.1001/jama.2012.62.
February 1, 2012
Mathias Masem, MD
JAMA. 2012;307(5):455-457. doi:10.1001/jama.2012.59.
February 1, 2012
Robert Darby, PhD
JAMA. 2012;307(5):455-457. doi:10.1001/jama.2012.61.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.